NORTHGATE SURGERY
NORTHGATE SURGERY, NORTHGATE, PONTEFRACT
CANCER 2
Cancer Reviewed since diagnosis
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CANCER 2 | 2005 | 51 | 56 | 91.1% | |
| CANCER 2 | 2006 | 68 | 72 | 94.4% | |
| CANCER 3 | 2007 | 23 | 24 | 95.8% | |
| CANCER 3 | 2008 | 30 | 31 | 96.8% | |
| CANCER 3 | 2009 | 12 | 12 | 100.0% | |
| CANCER 3 | 2010 | 24 | 24 | 100.0% | |
| CANCER 3 | 2011 | 17 | 17 | 100.0% | |
| CANCER 3 | 2012 | 15 | 16 | 93.8% | |
| CANCER 3 | 2013 | 37 | 37 | 100.0% | |
| CAN002 | 2014 | 27 | 29 | 93.1% | |
| CAN003 | 2015 | 39 | 41 | 95.1% | |
| CAN003 | 2016 | 47 | 47 | 100.0% | |
| CAN003 | 2017 | 39 | 41 | 95.1% | |
| CAN003 | 2018 | 26 | 26 | 100.0% | |
| CAN003 | 2019 | 48 | 51 | 94.1% | |
| CAN003 | 2020 | 55 | 60 | 91.7% | |
| CAN003 | 2021 | 42 | 68 | 61.8% | |
| CAN004 | 2022 | 67 | 67 | 100.0% | |
| CAN004 | 2023 | 71 | 71 | 100.0% |
